This expansion will focus on managing studies in India to not only support the global clinical drug development, but also the local business with clinical data and evidence.from Moneycontrol Business News http://bit.ly/2JO1QmQ
Thursday, May 30, 2019
Subscribe to:
Post Comments (Atom)
-
The value had touched a high of 22% of total market capitalisation of listed firms in June 2009, dropping to a low of 5.1% in September 2020...
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
No comments:
Post a Comment